Guardant Health revenue and financials
$170.69Change from previous close: −8.83%Absolute change: −$16.53
In the fiscal year ended December 2025, Guardant Health reported revenue of $982.02M (+32.88% year over year). The net loss was $416.28M.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +32.88%
- 2025 vs 2024
- Net margin
- -42.4%
- 2024: -59.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 2,014 | 1,486 | 1,786 | 1,610 | 2,204 | 2,272 | 963 | 587 |
| Current assets | 1,466 | 1,055 | 1,347 | 1,192 | 1,114 | 1,888 | 597 | 469 |
| Cash and equivalents | 378 | 526 | 1,134 | 142 | 492 | 833 | 143 | 141 |
| Short-term investments | 823 | 314 | 35.1 | 870 | 441 | — | — | — |
| Receivables | 138 | 110 | 88.8 | 97.3 | 97.7 | — | — | — |
| Inventory | 85.9 | 71.1 | 61.9 | 51.6 | 30.7 | — | — | — |
| Net property, plant and equipment | 305 | 279 | 303 | 342 | 314 | — | — | — |
| Goodwill | 77.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | — |
| Other intangible assets | 25.9 | 6.8 | 9.0 | 11.7 | 14.2 | — | — | — |
| Long-term investments | 6.5 | 16.1 | 107 | 43.3 | 737 | — | — | — |
| Current liabilities | 303 | 226 | 206 | 193 | 195 | 66.8 | 72.7 | 46.9 |
| Accounts payable | 54.4 | 38.6 | 51.7 | 68.9 | 38.5 | — | — | — |
| Long-term debt | 1,504 | 1,143 | 1,140 | 1,137 | 1,135 | — | — | — |
| Total debt | 1,710 | 1,336 | 1,354 | 1,369 | — | — | — | — |
| Total liabilities | 2,113 | 1,625 | 1,628 | 1,550 | 1,559 | 916 | 115 | 62.5 |
| Total equity (incl. minority) | -99.3 | -140 | 159 | 60.2 | 645 | — | — | — |
| Retained earnings | -2,995 | -2,578 | -2,142 | -1,662 | -1,008 | — | — | — |
| Minority interest | — | — | — | — | 0.0 | — | — | — |